| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/05/2006 | EP1676923A1 Sugar chain-cutting agent |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676912A2 Medical equipment containing a polypeptide having heparanase activity |
| 07/05/2006 | EP1676857A2 Receptor that binds trail |
| 07/05/2006 | EP1676855A2 Prenyl transferase inhibitors |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676845A1 New quinazoline derivatives |
| 07/05/2006 | EP1676839A2 Novel beta crystalline form of perindopril tert-butylamine salt, its preparation method and pharmaceutical compositions containing same |
| 07/05/2006 | EP1676575A2 Mucin production inhibitor |
| 07/05/2006 | EP1675850A1 Quinoline compounds and their uses |
| 07/05/2006 | EP1675625A1 Mechanism-based targeted pancreatic beta cell imaging and therapy |
| 07/05/2006 | EP1675566A1 Buccal, polar and non-polar spray containing diazepam |
| 07/05/2006 | EP1385505B1 Acne treatment with lipooxigenase inhibitors |
| 07/05/2006 | EP1368040B1 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 07/05/2006 | EP1313762B1 Suppressor gene |
| 07/05/2006 | EP1259241B1 The use of scopolamine salts |
| 07/05/2006 | EP1248626B1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/05/2006 | EP1234582B1 Concomitant drugs for treating glaucoma |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1196559B1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 07/05/2006 | EP1183026B1 Improved pharmaceutical formulations comprising ritonavir |
| 07/05/2006 | EP1105485B1 Human il-1 epsilon dna and polypeptides |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | EP1067958B1 Treatment of cardiac hypertrophy |
| 07/05/2006 | EP0918514B9 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma |
| 07/05/2006 | EP0733109B9 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/05/2006 | CN1798578A Medicinal compositions for improving oral absorption |
| 07/05/2006 | CN1798576A Drug for preventing or treating angiogenic eye diseases |
| 07/05/2006 | CN1796388A Sesamin/episesamin compositions |
| 07/05/2006 | CN1795916A Medication of prolonging life for dispelling senile plaque, and preparation method |
| 07/05/2006 | CN1795915A Medication for regulating qi and cultivating the mentality, and prepartion method |
| 07/05/2006 | CN1795913A Medicament drop pills for nourish qi and yin, recovering channels and vessels, and increasing the body fluid, and preparation method |
| 07/05/2006 | CN1795906A Composition for resisting stretch |
| 07/05/2006 | CN1795899A Growth substance for animal and preparation method |
| 07/05/2006 | CN1795895A Products of amino acid for fighting against senium, and preparation technique |
| 07/05/2006 | CN1795877A Ganoderma lucidum capsule of lycopene |
| 07/05/2006 | CN1795868A Medication possessing activity of fighting against senium |
| 07/05/2006 | CN1795854A Application of compound of Tetrahydro-proto-berberines class in pharmacy |
| 07/05/2006 | CN1262637C Formulation for primordial qi tonic wine and method for preparing same |
| 07/05/2006 | CN1262564C Extracting method for pork liver metal sulfur protein |
| 07/05/2006 | CN1262561C Synthetic poly peptide disturbing intracelluler signaling |
| 07/05/2006 | CN1262560C 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds |
| 07/05/2006 | CN1262556C Certain dinucleotides and their use as membrana mucosa cilium clearing and cilium vibration frequency regulating agent |
| 07/05/2006 | CN1262551C Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2006 | CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/05/2006 | CN1262542C Geldanamycin derivative and method of treating cancer same |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
| 07/05/2006 | CN1262289C Application of antimonocytic activity of extracts of piper betel leaves |
| 07/05/2006 | CN1262270C Application of levocarnitine and its derivative in preventing and treating high altitude diseases |
| 07/05/2006 | CN1262269C Compositions comprising blockers of L-DOPA renal cell transfer for treatment of Parkinson's disease |
| 07/04/2006 | US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 07/04/2006 | US7071335 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain |
| 07/04/2006 | US7071332 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 07/04/2006 | US7071316 Human Akt-3 |
| 07/04/2006 | US7071312 Epidermal differentiation factor |
| 07/04/2006 | US7071300 IGF antagonist peptides |
| 07/04/2006 | US7071234 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy |
| 07/04/2006 | US7071231 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
| 07/04/2006 | US7071225 Arylaminopropane analogues and their use for the treatment of glaucoma |
| 07/04/2006 | US7071218 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
| 07/04/2006 | US7071217 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 07/04/2006 | US7071216 Anticancer agents |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071195 Especially amino- or amido-ethyltetralin derivatives |
| 07/04/2006 | US7071192 Respiratory system disorders; infections in infants |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071187 Naphthyridine derivatives |
| 07/04/2006 | US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | US7071183 Use of inhibitors of the renin-angiotensin system |
| 07/04/2006 | US7071177 P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
| 07/04/2006 | US7071169 Pyrane derivatives as both ACE-and NEP-inhibitors |
| 07/04/2006 | US7071159 Solubility forms; skin disorders, rheumatic disorders, antidiabetic agents |
| 07/04/2006 | US7071158 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070969 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis |
| 07/04/2006 | US7070956 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 07/04/2006 | US7070814 Plant extracts for treatment of cancer |
| 07/04/2006 | US7070800 Inhalable powder containing tiotropium |
| 07/04/2006 | US7070784 Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues |
| 07/04/2006 | US7070766 Delivery of physiologically active compounds through an inhalation route |
| 07/04/2006 | US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns. |
| 07/04/2006 | US7070764 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070763 Delivery of diphenhydramine through an inhalation route |
| 07/04/2006 | US7070762 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070761 Aerosols; heating, vaporization, cooling |
| 07/04/2006 | US7070759 High dose radionuclide complexes for bone marrow suppression |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 07/04/2006 | CA2159419C Solid pharmaceutical composition comprising an excipient capable of binding water |
| 06/29/2006 | WO2006069329A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 06/29/2006 | WO2006068326A1 Novel polypeptide and the use thereof |
| 06/29/2006 | WO2006068254A1 Skin-whitening agent |
| 06/29/2006 | WO2006068232A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 06/29/2006 | WO2006068225A1 Method of inducing differentiation of skeletal muscle cell |